Novo CEO breaks silence after cyberattack: Everything points to a new hacker group
A cyberattack on Novo could disrupt operations and the supply of its products if systems or manufacturing were affected.
Source →The trace
How it reaches your house.
Starting from Novonix Ltd., we walked the supply graph hop by hop to the goods you buy and the companies you own. Each step is the engine’s reasoning, scored for confidence and cited where a source backs it.
First impact
Novo Nordisk →Shortage riskGLP-1 Receptor Agonist Peptide API (Semaglutide / Liraglutide Type)
If the cyberattack disrupts Novo Nordisk's manufacturing or systems, this 95% share, sole-qualified supply source would make GLP-1 API availability tighten sharply.
84% confidenceNovo Nordisk →Shortage riskRecombinant Insulin API (Bulk Drug Substance)
A Novo systems or production outage would cut supply of this insulin API, and its 45% market share plus 36-month replacement lead time imply a material shortage.
79% confidenceNovo Nordisk →Shortage riskHop 2
Recombinant Insulin API (Bulk Drug Substance) →Shortage riskThis API is a critical input into insulin with dependency strength 0.98, so a shortage here should directly reduce insulin availability.
96% confidenceDairy Starter Cultures →Shortage riskDairy starter cultures are a critical cheese input, so a disruption at Novo should directly tighten cheese output and availability.
95% confidenceGLP-1 Receptor Agonist Peptide API (Semaglutide / Liraglutide Type) →Shortage riskGLP-1 drugs (Ozempic, Wegovy, Mounjaro)
If Novo's cyberattack constrains this API, the downstream GLP-1 drug supply is likely to tighten because the edge is marked critical with very high dependency strength (0.95).
Hop 3
Eli Lilly and Company →Shortage riskUnited Therapeutics CorporationUTHR
Lilly is disclosed as the sole manufacturer for Adcirca, so a Lilly cyber-disruption would very likely create a direct supply shortage for United Therapeutics.
94% confidenceInsulin →DelaysSterile Fill-Finish
Sterile fill-finish is the last production step before shipment, so a cyberattack affecting manufacturing systems can directly slow insulin supply.
87% confidenceInsulin →DelaysFormulation
If Novo's systems or manufacturing are disrupted, insulin formulation can be delayed before finished product is released.
83% confidence
Where it lands
What you buy, and what you own.
Goods you buy
Insulin · Cheese · GLP-1 drugs (Ozempic, Wegovy, Mounjaro) · Infant formula · Dairy and eggs
Companies you may own
NVOLLYSNYDSFIR.ASBASF SE (Nutrition & Health)BIOCON.NSIntas Pharmaceuticals / Accord HealthcareAbbott Nutrition (Abbott Laboratories)FrieslandCampina Ingredients (FrieslandCampina)Kerry GroupIFFSacco SystemUTHRFULCNVAXAMPHREGNCYTK
Tap a company to see what it told the SEC could break it.
In the MyPRIA app, this is checked against your own holdings.